07/07/2005 The Asahi Shimbun
A durable new drug that prevents HIV from entering human cells and causes almost no side effects has been developed by a team of researchers at Kumamoto University.
The new drug, code named AK602, was reported by the research team's leader, Hiroaki Mitsuya, at the International Congress on AIDS in Asia and the Pacific in Kobe on Tuesday.
The drug's main feature is that it shuts out the AIDS virus at the point when it tries to intrude into a human cell.
Basically, it works differently than the available drugs by affecting the receptor cells, making them able to respond to the virus' continuing micro-changes that the virus makes to create resistance to the drugs that go after the virus itself. In short, it's a whole new tack (giving, possibly, a whole new take on animae!)